{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:06:05Z","timestamp":1788437165668,"version":"build-2803163510"},"reference-count":41,"publisher":"The Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Epidural steroid injections (ESIs) are a common, effective treatment of lumbar radiculopathy and sciatica. Although the negative skeletal effects of oral glucocorticoids are well established, little is known about the impact of ESI on bone quality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To investigate the relationship between ESI exposure and volumetric bone mineral density (vBMD) at the lumbar spine (LS) using central quantitative CT.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Retrospective study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>University hospital outpatient facility.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients<\/jats:title>\n                  <jats:p>All patients had CT scans of the LS between 2011 and 2016. Cases received at least three ESIs prior to the date of CT (n = 121). Controls were matched for age and sex (n = 121).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>Cumulative ESI dose was calculated. vBMD was measured at T12 through L5 using QCT Pro phantomless software (MindWays).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Mean age of subjects was 65 \u00b1 14 years, and 49% were women. Median number of ESIs was 4 (range: 3 to 16). Median cumulative ESI dosage was 340 mg of triamcinolone or equivalent (range: 150 to 1400 mg). Compared with controls, ESI subjects had lower vBMD at each vertebral level. Higher cumulative dose was associated with lower mean vBMD at T12 to L5 (r = \u20130.22, P = 0.02).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Greater cumulative ESI dose was related to lower vBMD at the LS. To our knowledge, this is the first study to measure vBMD in patients treated with ESIs. Prospective studies are needed to confirm these findings and to help identify the best strategies for preventing bone loss in this population.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2018-00558","type":"journal-article","created":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T18:10:40Z","timestamp":1530555040000},"page":"3405-3410","source":"Crossref","is-referenced-by-count":17,"title":["Lower Spine Volumetric Bone Density in Patients With a History of Epidural Steroid Injections"],"prefix":"10.1210","volume":"103","author":[{"given":"Yi","family":"Liu","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolic Bone Disease, Hospital for Special Surgery, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A","family":"Carrino","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hospital for Special Surgery, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander S","family":"Dash","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolic Bone Disease, Hospital for Special Surgery, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Chukir","sequence":"additional","affiliation":[{"name":"Department of Medicine, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huong","family":"Do","sequence":"additional","affiliation":[{"name":"Clinical Data Core, Healthcare Research Institute, Hospital for Special Surgery, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S","family":"Bockman","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolic Bone Disease, Hospital for Special Surgery, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander P","family":"Hughes","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Hospital for Special Surgery, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M","family":"Press","sequence":"additional","affiliation":[{"name":"Department of Physiatry, Hospital for Special Surgery, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M","family":"Stein","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolic Bone Disease, Hospital for Special Surgery, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,7,2]]},"reference":[{"issue":"4","key":"2020071622284106700_B1","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/ALN.0b013e31829c2ddd","article-title":"Epidural injections for spinal pain: a systematic review and meta-analysis evaluating the \u201ccontrol\u201d injections in randomized controlled trials","volume":"119","author":"Bicket","year":"2013","journal-title":"Anesthesiology"},{"issue":"5","key":"2020071622284106700_B2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.7326\/M15-0934","article-title":"Epidural corticosteroid injections for radiculopathy and spinal stenosis: a systematic review and meta-analysis","volume":"163","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"issue":"5","key":"2020071622284106700_B3","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jaci.2013.08.040","article-title":"Glucocorticoid-induced osteoporosis: an update on effects and management","volume":"132","author":"Buehring","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2020071622284106700_B4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.rdc.2015.08.005","article-title":"Glucocorticoid-induced osteoporosis","volume":"42","author":"Whittier","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"2020071622284106700_B5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"J Clin Invest"},{"issue":"5","key":"2020071622284106700_B6","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/art.24445","article-title":"Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL","volume":"60","author":"Hofbauer","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"4","key":"2020071622284106700_B7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tem.2013.12.006","article-title":"Glucocorticoids and bone: local effects and systemic implications","volume":"25","author":"Henneicke","year":"2014","journal-title":"Trends Endocrinol Metab"},{"issue":"20","key":"2020071622284106700_B8","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","article-title":"Teriparatide or alendronate in glucocorticoid-induced osteoporosis","volume":"357","author":"Saag","year":"2007","journal-title":"N Engl J Med"},{"issue":"11","key":"2020071622284106700_B9","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1002\/art.24879","article-title":"Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial","volume":"60","author":"Saag","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"9671","key":"2020071622284106700_B10","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(09)60250-6","article-title":"Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial","volume":"373","author":"Reid","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"2020071622284106700_B11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s12020-016-1146-8","article-title":"Glucocorticoid-induced osteoporosis: pathophysiological role of GH\/IGF-I and PTH\/VITAMIN D axes, treatment options and guidelines","volume":"54","author":"Mazziotti","year":"2016","journal-title":"Endocrine"},{"issue":"1","key":"2020071622284106700_B12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jbmr.2708","article-title":"Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research","volume":"31","author":"Adler","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2020071622284106700_B13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11914-010-0003-6","article-title":"Glucocorticoid-induced osteoporosis: management update","volume":"8","author":"Adler","year":"2010","journal-title":"Curr Osteoporos Rep"},{"issue":"1","key":"2020071622284106700_B14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3899\/jrheum.090411","article-title":"Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis","volume":"37","author":"Devogelaer","year":"2010","journal-title":"J Rheumatol"},{"issue":"8","key":"2020071622284106700_B15","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/art.40137","article-title":"2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"69","author":"Buckley","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"2020071622284106700_B16","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/PHM.0000000000000001","article-title":"Changes in blood glucose and cortisol levels after epidural or shoulder intra-articular glucocorticoid injections in diabetic or nondiabetic patients","volume":"93","author":"Moon","year":"2014","journal-title":"Am J Phys Med Rehabil"},{"issue":"6","key":"2020071622284106700_B17","first-page":"461","article-title":"Salivary cortisol concentration changes after epidural steroid injection","volume":"15","author":"Chon","year":"2012","journal-title":"Pain Physician"},{"issue":"3","key":"2020071622284106700_B18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1213\/00000539-199409000-00017","article-title":"Epidural triamcinolone suppresses the pituitary-adrenal axis in human subjects","volume":"79","author":"Kay","year":"1994","journal-title":"Anesth Analg"},{"issue":"6","key":"2020071622284106700_B19","first-page":"557","article-title":"Effects of two different doses of epidural steroid on blood glucose levels and pain control in patients with diabetes mellitus","volume":"16","author":"Kim","year":"2013","journal-title":"Pain Physician"},{"issue":"12","key":"2020071622284106700_B20","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1359\/jbmr.060903","article-title":"Volumetric BMD and vascular calcification in middle-aged women: the Study of Women\u2019s Health Across the Nation","volume":"21","author":"Farhat","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2020071622284106700_B21","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1002\/art.11283","article-title":"Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy","volume":"48","author":"Van Staa","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"11","key":"2020071622284106700_B22","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1210\/jc.2014-2177","article-title":"Abnormalities in cortical bone, trabecular plates, and stiffness in postmenopausal women treated with glucocorticoids","volume":"99","author":"Sutter","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2020071622284106700_B23","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1148\/rg.287085004","article-title":"Flat-panel volume CT: fundamental principles, technology, and applications","volume":"28","author":"Gupta","year":"2008","journal-title":"Radiographics"},{"issue":"9","key":"2020071622284106700_B24","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1002\/jbmr.428","article-title":"Simultaneous screening for osteoporosis at CT colonography: bone mineral density assessment using MDCT attenuation techniques compared with the DXA reference standard","volume":"26","author":"Pickhardt","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2020071622284106700_B25","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/art.10277","article-title":"Quantitative computed tomography of the lumbar spine, not dual x-ray absorptiometry, is an independent predictor of prevalent vertebral fractures in postmenopausal women with osteopenia receiving long-term glucocorticoid and hormone-replacement therapy","volume":"46","author":"Rehman","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2020071622284106700_B26","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s00198-004-1736-9","article-title":"Differences in hip quantitative computed tomography (QCT) measurements of bone mineral density and bone strength between glucocorticoid-treated and glucocorticoid-naive postmenopausal women","volume":"16","author":"Lian","year":"2005","journal-title":"Osteoporos Int"},{"issue":"6","key":"2020071622284106700_B27","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/00004728-200011000-00015","article-title":"The use of clinical CT for baseline bone density assessment","volume":"24","author":"Hopper","year":"2000","journal-title":"J Comput Assist Tomogr"},{"issue":"3","key":"2020071622284106700_B28","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00198-015-3318-4","article-title":"Opportunistic screening for osteoporosis using the sagittal reconstruction from routine abdominal CT for combined assessment of vertebral fractures and density","volume":"27","author":"Lee","year":"2016","journal-title":"Osteoporos Int"},{"issue":"11","key":"2020071622284106700_B29","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1177\/0091270003258651","article-title":"Dose equivalency evaluation of major corticosteroids: pharmacokinetics and cell trafficking and cortisol dynamics","volume":"43","author":"Mager","year":"2003","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"2020071622284106700_B30","first-page":"229","article-title":"Changes in bone mineral density in postmenopausal women treated with epidural steroid injections for lower back pain","volume":"15","author":"Kang","year":"2012","journal-title":"Pain Physician"},{"issue":"1","key":"2020071622284106700_B31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1155\/2014\/870145","article-title":"Relationship between bone mineral density and the frequent administration of epidural steroid injections in postmenopausal women with low back pain","volume":"19","author":"Kim","year":"2014","journal-title":"Pain Res Manag"},{"issue":"25","key":"2020071622284106700_B32","doi-asserted-by":"crossref","first-page":"E1567","DOI":"10.1097\/BRS.0b013e318270280e","article-title":"Effect of epidural steroid injection on bone mineral density and markers of bone turnover in postmenopausal women","volume":"37","author":"Al-Shoha","year":"2012","journal-title":"Spine"},{"issue":"6","key":"2020071622284106700_B33","first-page":"441","article-title":"Low bone mineral density, but not epidural steroid injection, is associated with fracture in postmenopausal women with low back pain","volume":"15","author":"Yi","year":"2012","journal-title":"Pain Physician"},{"issue":"1","key":"2020071622284106700_B34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s10067-002-0648-3","article-title":"Lack of relationships between cumulative methylprednisolone dose and bone mineral density in healthy men and postmenopausal women with chronic low back pain","volume":"22","author":"Dubois","year":"2003","journal-title":"Clin Rheumatol"},{"issue":"11","key":"2020071622284106700_B35","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1210\/jc.2012-2099","article-title":"Central QCT reveals lower volumetric BMD and stiffness in premenopausal women with idiopathic osteoporosis, regardless of fracture history","volume":"97","author":"Cohen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2020071622284106700_B36","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","article-title":"Oral corticosteroids and fracture risk: relationship to daily and cumulative doses","volume":"39","author":"van Staa","year":"2000","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"2020071622284106700_B37","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis","volume":"13","author":"van Staa","year":"2002","journal-title":"Osteoporos Int"},{"issue":"5","key":"2020071622284106700_B38","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2165\/00002018-200831050-00005","article-title":"Inhaled corticosteroids and the risk of fractures in older adults: a systematic review and meta-analysis","volume":"31","author":"Etminan","year":"2008","journal-title":"Drug Saf"},{"issue":"5","key":"2020071622284106700_B39","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s40265-014-0202-z","article-title":"Meta-review: adverse effects of inhaled corticosteroids relevant to older patients","volume":"74","author":"Mattishent","year":"2014","journal-title":"Drugs"},{"issue":"1","key":"2020071622284106700_B40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jbmr.506","article-title":"Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT","volume":"27","author":"Yu","year":"2012","journal-title":"J Bone Miner Res"},{"key":"2020071622284106700_B41","doi-asserted-by":"crossref","unstructured":"Kendler\n              DL\n            , MarinF, ZerbiniCAF, RussoLA, GreenspanSL, ZikanV, BagurA, Malouf-SierraJ, LakatosP, Fahrleitner-PammerA, LespessaillesE, MinisolaS, BodyJJ, GeusensP, M\u00f6rickeR, L\u00f3pez-RomeroP. Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial [published online ahead of print 9 November 2017]. Lancet. doi: 10.1016\/S0140-6736(17)32137-2.","DOI":"10.1016\/S0140-6736(17)32137-2"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/9\/3405\/25685881\/jc.2018-00558.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/9\/3405\/25685881\/jc.2018-00558.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T10:50:31Z","timestamp":1594983031000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/103\/9\/3405\/5047292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,2]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2018-00558","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,9]]},"published":{"date-parts":[[2018,7,2]]}}}